Which hedge funds own LGND? LIGAND PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
4 of the hedge funds tracked by WhaleCreep disclosed a position in LGND (LIGAND PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $33.6m in total. The largest holder by portfolio weight is WCM Investment Management at 0.0% of its book. 2 managers opened a new position this quarter: Brevan Howard Capital Management, Millennium Management. 1 exited: Marshall Wace.
4tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold LGND? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| WCM Investment Management | Q2 2026 | 0.0% | $14.0m | 44,570 | -0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $17.9m | 56,515 | -28% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $508.0k | 1,607 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $1.3m | 3,975 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.0% | $1.5m |
How has hedge fund ownership of LGND changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $33.6m |
| Q1 2026 | 4 | $27.1m |
| Q4 2025 | 2 | $9.5m |
| Q3 2025 | 2 | $3.2m |
| Q2 2025 | 1 | $357.0k |
| Q3 2024 | 1 | $300.3k |
| Q2 2024 | 1 | $1.5m |
| Q1 2024 | 1 | $3.4m |
| Q4 2023 | 2 | $6.0m |
| Q3 2023 | 1 | $3.3m |
| Q2 2023 | 1 | $3.1m |
| Q1 2023 | 4 | $2.6m |
| Q4 2022 | 2 | $2.3m |
| Q3 2022 | 1 | $1.4m |
| Q2 2022 | 2 | $1.9m |
| Q1 2022 | 3 | $9.7m |
Counts every tracked manager that disclosed LGND in that quarter's filing, including managers that have since stopped filing.